Abstract
Despite increasing use and expanding indications for the Impella (ABIOMED, Danvers, MA) heart pump, there are limited data supporting its benefit compared with intra-aortic balloon pump (IABP) support in patients undergoing percutaneous coronary intervention (PCI). In this context, we evaluated the
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have